Assembly Bill A1609

2017-2018 Legislative Session

Relates to synthetic cannabinoids, synthetic cannabinoid analog and substituted cathinones and prohibiting the production and sale thereof

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

multi-Sponsors

2017-A1609 (ACTIVE) - Details

See Senate Version of this Bill:
S3829
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §3302, Pub Health L; amd §220.00, Pen L; add §399-hh, Gen Bus L
Versions Introduced in Other Legislative Sessions:
2011-2012: A8913
2013-2014: A5441
2015-2016: A5453, A5454, A8697, S4720
2019-2020: A4491, A6156
2021-2022: A1323, A6465
2023-2024: A197

2017-A1609 (ACTIVE) - Summary

Relates to synthetic cannabinoids, synthetic cannabinoid analog and substituted cathinones and prohibits the production and sale thereof.

2017-A1609 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1609
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 12, 2017
                                ___________
 
 Introduced  by  M.  of  A.  MAGNARELLI,  BARCLAY,  COOK,  MOSLEY, SIMON,
   PEOPLES-STOKES, GALEF, OTIS, BUCHWALD,  BLAKE,  WOERNER,  JEAN-PIERRE,
   ORTIZ -- Multi-Sponsored by -- M. of A. HOOPER, HYNDMAN, MAGEE, RAMOS,
   SKARTADOS -- read once and referred to the Committee on Health
 
 AN  ACT  to  amend  the public health law, the penal law and the general
   business law, in relation to synthetic cannabinoids, synthetic  canna-
   binoid   analog   and   substituted  cathinones  and  prohibiting  the
   production and sale thereof
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3302 of the public health law is amended by adding
 three new subdivisions 44, 45 and 46 to read as follows:
   44. "SYNTHETIC CANNABINOID" MEANS ANY CHEMICAL COMPOUND THAT IS CHEMI-
 CALLY SYNTHESIZED AND:
   (A) HAS BEEN DEMONSTRATED TO HAVE A BINDING ACTIVITY AT  ONE  OR  MORE
 CANNABINOID RECEPTORS; OR
   (B) IS A CHEMICAL ISOMER, SALT OR SALT OF AN ISOMER OF A COMPOUND THAT
 HAS  BEEN  DEMONSTRATED TO HAVE BINDING ACTIVITY AT ONE OR MORE CANNABI-
 NOID RECEPTORS; OR
   (C) HAS BEEN DESIGNATED IN REGULATION BY THE COMMISSIONER AS  BEING  A
 SYNTHETIC CANNABINOID OR SYNTHETIC CANNABINOID ANALOG.
   "SYNTHETIC  CANNABINOID"  DOES  NOT  INCLUDE ANY PRODUCT THAT HAS BEEN
 APPROVED FOR MEDICAL USE BY THE UNITED STATES  FOOD  AND  DRUG  ADMINIS-
 TRATION.
   45. "SYNTHETIC CANNABINOID ANALOG" MEANS ANY CHEMICAL THAT IS SUBSTAN-
 TIALLY  SIMILAR  IN  CHEMICAL  STRUCTURE TO A CHEMICAL COMPOUND THAT HAS
 BEEN DETERMINED TO HAVE BINDING ACTIVITY  AT  ONE  OR  MORE  CANNABINOID
 RECEPTORS.  IT DOES NOT INCLUDE ANY PRODUCTS THAT HAVE BEEN APPROVED FOR
 MEDICAL USE BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION.
   46. "SUBSTITUTED CATHINONE" MEANS ANY CHEMICAL COMPOUND THAT IS CHEMI-
 CALLY SYNTHESIZED AND:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.